Drugs / Peanut Oral Powder
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06297083 | May 2024 → May 2027 | food allergy | Murdoch Childrens Research Institute | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Peanut Oral Powder | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06297083 ↗ |
| Known as | PEANUT POWDER | “Peanut Oral Powder [PEANUT POWDER]” NCT06297083 ↗ |
| Route | Oral | “Peanut oral immunotherapy” NCT06297083 ↗ |